Open AccessCardiovascular Benefits and Risk Profiles of Oral Anti-Diabetic Agents: Current Evidence and Ongoing Trials
Author(s) -
YiCheng Chang,
Shih-Che Hua,
YiCheng Chang
Publication year - 2015
Publication title -
journal of cardiology and therapy
Language(s) - English
Resource type - Journals
eISSN - 2312-122X
pISSN - 2309-6861
DOI - 10.17554/j.issn.2309-6861.2015.02.87
Subject(s) - medicine , metformin , type 2 diabetes , empagliflozin , clinical trial , randomized controlled trial , diabetes mellitus , pioglitazone , glycemic , rosiglitazone , intensive care medicine , pharmacology , endocrinology